Costar Technologies, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Costar Technologies, Inc. (OTC: CSTI) designs, develops, manufactures and distributes a comprehensive range of products for the video surveillance and machine vision markets; its portfolio encompasses surveillance cameras including multi- and single-sensor megapixel models (MegaIP and ConteraIP), ruggedized high-speed dome and outdoor cameras with advanced optics and IP67-rated enclosures (CostarHD), network video recorders (NVRs), digital video recorders (DVRs), video management software (VMS such as ConteraVMS), monitors, lenses, cables, lighting, electronic accessories and customized security systems (Innotech SMARTCONTROL and Intelli-FLEX); through subsidiaries Arecont Vision Costar, Costar Video Systems, CostarHD, Innotech Security and IVS Imaging, the company serves commercial, financial, retail, education, healthcare, government, military, border security, highways, manufacturing, R&D, robotics and industrial applications worldwide with manufacturing in the United States, China and Korea. Headquartered in Coppell, Texas, Costar Technologies operates as a subsidiary of IDIS Co., Ltd. following the completion of its acquisition in August 2023, a strategic merger building on over 20 years of partnership that enhances product offerings, R&D capabilities with nearly 200 specialists, North American distribution networks, financial stability and global reach while enabling customers to access combined Costar and IDIS solutions. The company reported financial results for the year ended December 31, 2022 in May 2023 and held a special stockholder meeting in May 2023, reflecting ongoing operational integration and governance post-acquisition.
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
Costar Data Shows Big Six Q1 Office Investment Volumes at Their Highest Since 2018
Costar Group: Third Point Is Being Impatient (Rating Upgrade)
Calls of the Day: Applovin Corp, Costar, Cheniere, Spotify Tech and Raymond James
IDIS Co., Ltd. Announces the Closing of its Acquisition of Costar Technologies, Inc.
Costar Technologies, Inc. Announces Financial Results For the Fourth Quarter and Year Ended December 31, 2020
Costar Technologies, Inc. Announces Retirement of the Chairman of its Board of Directors
Costar Technologies, Inc. Announces Financial Results For the Third Quarter Ended September 30, 2020